Organigram Holdings | OGI - 流动资产



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 137.92M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


流动资产 更改 日
Acasti Pharma USD 19.21M 1.91M 2025-12
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Canopy Growth CAD 529.47M 4.8M 2026-03
Cronos Group USD 912.03M 15.85M 2026-06
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Moderna USD 5.82B 45M 2026-06
Organigram Holdings CAD 250.09M 6.46M 2026-03
Organon & Co USD 5.11B 179M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 10.06B 861.1M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06